Padrines M, Rohanizadeh R, Damiens C, Heymann D, Fortun Y
Laboratoire de physiopathologie de la résorption osseuse, EE 99-01 Université de Nantes, 1 place Alexis Ricordeau, BP 84215, 44042 Nantes Cedex 01, France.
Connect Tissue Res. 2000;41(2):101-8. doi: 10.3109/03008200009067662.
This study investigated the concentration-dependent effect of vitronectin (VN), a glycoprotein of the bone matrix, on apatite formation and growth. Precipitation trials in metastable solution and in a pH-controlled solution system showed an inhibition of apatite microcrystal formation by VN. In the presence of biphasic calcium-phosphate ceramic, transmission electron microscopy showed a reduction of precipitated microcrystal size: precipitates were significantly smaller than in ionic simulated body fluid without proteins or in the presence of type I collagen as a negative control. Moreover, the size of the precipitated microcrystals was reduced in a dose-dependent manner. Two indirect methods showed that calcium-phosphate precipitation was inhibited by VN. It would appear that VN prevents apatite formation by inhibiting the growth of apatite crystals rather than by secondary nucleation, as in the case of osteopontin, a bone-specific protein.
本研究调查了骨基质糖蛋白玻连蛋白(VN)对磷灰石形成和生长的浓度依赖性效应。在亚稳溶液和pH控制的溶液体系中进行的沉淀试验表明,VN可抑制磷灰石微晶的形成。在双相磷酸钙陶瓷存在的情况下,透射电子显微镜显示沉淀微晶尺寸减小:沉淀物明显小于无蛋白质的离子模拟体液或作为阴性对照的I型胶原存在时的情况。此外,沉淀微晶的尺寸以剂量依赖性方式减小。两种间接方法表明,VN可抑制磷酸钙沉淀。似乎VN是通过抑制磷灰石晶体的生长而非像骨特异性蛋白骨桥蛋白那样通过二次成核来阻止磷灰石形成。